Quantitative structure activity relationship studies of piperazinyl phenylalanine derivatives as VLA-4/VCAM-1 inhibitors

Medicinal Chemistry

Volumn 5, Issue 5, 2009, Pages 446-454

  Bhargava, Dinesh ^a   Karthikeyan, C ^a   Moorthy, N S H N ^a   Trivedi, Piyush ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Piperazinyl phenylalanine; QSAR; V life; VLA 4 VCAM 1

Indexed keywords

PHENYLALANINE DERIVATIVE; PIPERAZINYLPHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; LIPOPHILICITY; MOLECULAR MODEL; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

HUMANS; INHIBITORY CONCENTRATION 50; INTEGRIN ALPHA4BETA1; JURKAT CELLS; PHENYLALANINE; PIPERAZINES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR CELL ADHESION MOLECULE-1;

EID: 70349090169     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609789117822     Document Type: Article

References (12)

1. Osamu, S.; Kiminori, O.; Eri, A.; Yuji, N.; Hiroko, M.; Hiroaki, N.; Eiichi, F.; Yoshisuke, N. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinyl phenylalanine derivatives. Bioorg. Med. Chem. Lett., 2008, 18, 1053-1057.
2. George, A.D.; Theodore, K.; Ermenegilda, M.C.; Gail, V.R.; Richard, A.M.; Sharon, T.; William, K.H. N-aryl 2,6-dimethoxybiphenylalanine analogues as VLA-4 antagonists. Bioorg. Med. Chem. Lett., 2002, 12, 729-731.
3. Pretolani, M.; Ruffie, C.; Lapo e Silva, J.R.; Joseph, D.; Lobb, R.R.; Vargaftig, B.B. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyper-reactivity and cellular infiltration in the guinea pig airways. J. Exp. Med., 1994, 180, 795-805.
4. Ianaro, A.; Cicala, C.; Calignano, A.; Koteliansky, V.; Gotwals, P.; Bucci, M.; Gerli, R.; Santucci, L.; Fiorucci, S.; Cirino, G. Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis. Lab. Invest., 2000, 80, 73-80.
5. Keszthelyi, E.; Karlik, S.; Hydruk, S.; Rice, G.P.; Gordon, G.; Yednock, T.; Horner, H. Evidence for a prolonged role of alpha sub 4 integrin throughout active experimental allergic encephalomyelitis. Neurology, 1996, 47, 1053-1059.
6. Podolsky, D.K.; Lobb, R.R.; King, N.; Benjamin, C.D.; Pepinsky, B.; Sehgal, P.; de Beaumont, M. Attenuation of colitis in the cotton-top tamarin by anti-&agr 4 integrin monoclonal antibody. J. Clin. Invest., 1993, 92, 372-380.
7. Miller, D.H.; Khan, O.A.; Sheremata, W.A.; Blumhardt, L.D.; Rice, G.P.; Libonati, M.A.; Willmer-Hulme, A.J.; Dalton, C.M.; Miszkiel, K.A.; O'Connor, P.W.N. A controlled trial of natali-zumab for relapsing multiple sclerosis. Eng. J. Med., 2003, 348, 15-23.
8. Abraham, W.M.; Gill, A.; Ahmed, A.; Sielczak, M.W.; Lauredo, I.T.; Botinnikova, Y.; Lin, K.C.; Pepinsky, B.; Leone, D.R.; Lobb, R.R.; Adams, S.P. A small-molecule, tight-binding inhibitor of the integrin alpha -4 beta-1 blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am. J. Respir. Crit. Care Med., 2000, 162, 603-611.
9. Marie-Agne's, L.; Fabienne, B.; Philippe, C.; Laurent, D.; Francoise de, L.D.; Thierry, D.; Abdoulaye, G.; Gérald, G.; Jean-Claude, H.; Laszlo, K.; Laurent, K.; Jean-Marie, N.; Stéphanie, N.; Luc, Q.; Sylvain, R.; Valérie, V.; Laurent, P. 2,6-Quinolinyl derivatives as potent VLA-4 antagonists. Bioorg. Med. Chem. Lett., 2007, 17, 142-146.
10. www.Vlifesciences.com
11. V-Life, molecular design suite™ 3.5, Developed by V-Life Technologies, Pune, India, 2006.
12. OPENSTAT software ver. 4, developed by Bill Miller from Iowa State University, USA, March, 2008.